Skip to main content
. 2021 Oct 19;11(10):1546. doi: 10.3390/biom11101546

Table 1.

Frequent causes of C1 metabolic disorders.

  • Cellular deficiency in one or more of the vitamins B6, B12 and folate:

  • (a)
    Insufficient intake via food:
    1. Vitamin B12 deficiency in vegetarians and vegans, who do not supplement vitamin B12 [18,19].
    2. All three vitamins in elderly subjects, especially in nursing homes [18,20].
    3. Pronounced folic acid deficiency in industrialized countries around the world [21,22]. It is the main reason for folic acid supplementation in more than 70 countries [23].
  • (b)

    Loss due to inadequate preparation, especially for folic acid [24].

  • (c)

    Increased need during pregnancy, lactation and hemodialysis.

  • (d)

    Insufficient intestinal absorption: unspecific in celiac disease, inflammatory bowel diseases and resections, specific for B12 with intrinsic factor deficiency or auto-antibodies against parietal cells [25,26].

  • (e)

    Intracellular, metabolic causes, e.g., accumulation of 5-methyl-THF in the case of pronounced B12 deficiency (“folic acid trap”), leading to a deficiency of THF-dependent C1 compounds, despite adequate folic acid intake [6,7].

  • (f)

    Side effects of pharmaceuticals on absorption or metabolism of particular vitamins, e.g., anticonvulsant drugs, levodopa, metformin [27].

  • Common genetic variants in C1 metabolism:

  • (a)

    MTHFR: C677T point mutation in homozygous form (TT) in 12–15% of the European population, which can be compensated by adequate folic acid intake [28]. Combined occurrence of the heterozygous form (CT) with the heterozygous form (AC) of another point mutation—A1298C—is relatively common (approximately 25%) and can be associated with various disturbances [29,30].

  • (b)

    CBS: About 230 known mutations that are rarely homozygous. In the heterozygous form, they potentially occur in around 1% of the European population [31].

  • Lifestyle factors (the underlying mechanisms are often not clear or multifactorial and usually linked to their effect on plasma HCys level):

  • (a)

    Acquired reductions in the activity of enzymes, e.g., methionine synthase due to acetaldehyde in alcoholics [32].

  • (b)

    Cigarette smoking appears as an independent determinant of HCys levels, with an increase in approx. 1% per cigarette smoked [33].

  • (c)

    Relatively large amounts of coffee consumption are necessary to increase HCys [34].

  • Oxidative stress:

  • Particularly nitric oxide inhibits methionine synthase directly, as well as by binding cobalamin [35]. Consequently, increase in plasma HCys is accompanied by that of markers of NO formation, e.g., citrulline. In addition, methylmalonic acid strongly increases as NO inhibits cobalamin transport from cytosol into mitochondria [36].